Rhonda Farnum, SVP of Theravance Biopharma TBPH, has filed 0 purchases and 22 sales on the open market. Over the past 12 months that comes to a net sale of $1.2M. The latest trade was on 09/23.

RF

RF

Rhonda Farnum

SVP, Comm & Medical Affairs

Company

Theravance Biopharma TBPH

First filing

23/02/22

Trades

44 trades

Buys / sales

0 / 22

12-month net buying

−$1.2M

Last trade

09/23

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Theravance BiopharmaTBPH	Open-market sale10b5-1 plan	06/15	06/17	13,314 sh3 trades	$16.39avg.	$218,183.18	−5.4%
Theravance BiopharmaTBPH	Open-market sale10b5-1 plan	03/16	03/18	31,067 sh3 trades	$13.96avg.	$433,695.36	−11.8%
Theravance BiopharmaTBPH	Open-market sale10b5-1 plan	25/12/03	25/12/05	31,067 sh3 trades	$18.75avg.	$582,506.25	−10.1%
Theravance BiopharmaTBPH	Open-market sale10b5-1 plan	25/07/14	25/07/16	10,000 sh3 trades	$11.39avg.	$113,900	−3.0%
Theravance BiopharmaTBPH	Open-market sale10b5-1 plan	25/06/02	25/06/04	24,000 sh	$11.00	$264,000	−6.6%
Theravance BiopharmaTBPH	Open-market sale10b5-1 plan	25/04/21	25/04/23	4,000 sh	$9.00	$36,000	−1.1%
Theravance BiopharmaTBPH	Open-market sale10b5-1 plan	25/01/21	25/01/23	4,000 sh	$9.00	$36,000	−1.3%
Theravance BiopharmaTBPH	Open-market sale	24/11/11	24/11/13	4,000 sh	$9.00	$36,000	−1.2%
Theravance BiopharmaTBPH	Open-market sale10b5-1 plan	24/07/10	24/07/12	4,000 sh	$9.00	$36,000	−1.2%
Theravance BiopharmaTBPH	Open-market sale10b5-1 plan	24/02/22	24/02/22	1,254 sh	$8.71	$10,922.34	−0.4%
Theravance BiopharmaTBPH	Open-market sale10b5-1 plan	23/11/21	23/11/22	1,378 sh	$10.29	$14,179.62	−0.4%
Theravance BiopharmaTBPH	Open-market sale10b5-1 plan	23/08/22	23/08/24	1,807 sh	$9.47	$17,112.29	−0.5%
Theravance BiopharmaTBPH	Open-market sale	23/06/08	23/06/12	1,790 sh	$11.13	$19,922.7	−0.5%
Theravance BiopharmaTBPH	Open-market sale	23/03/09	23/03/13	4,000 sh	$10.20	$40,800	−1.1%